Trademarkia Logo

Canada

C$
REPLINVI
SEARCHED

on 27 Sept 2024

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2297662 filed on 10th Nov 2023

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

REPLINVI

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely central nervous system infections, brain diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunological diseases, namely autoimmune diseases, immune deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the musculoskeletal system, namely connective tissue diseases, bone diseases, spinal diseases, backache, fractures, sprains, cartilage injuries; Pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, pelvic inflammatory disease; Pharmaceutical preparations for use in dermatology, namely for the prevention and treatment of psoriasis, urticaria, hidradenitis suppurativa, dermatitis, diseases affecting skin pigmentation, sexually transmitted diseases; Pharmaceutical preparations used in oncology; Pharmaceutical preparations used in hematology, namely for the treatment of blood disorders; Pharmaceutical preparations used for tissue and organ transplantation; Pharmaceutical preparations used in ophthalmology; Pharmaceutical preparations used in gastroenterology; Pharmaceutical preparations for the prevention and treatment of eye disorders and diseases; Systemic and topical anti-infectives, antibacterials, antivirals, antibiotics, antifungals.


Classification kind code

11

Mark Details


Serial Number

2297662

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 256
on 7th Oct 2024
Notification of Possible Opposition Sent
Submitted for opposition 48
on 7th Oct 2024
Agent Changed
Submitted for opposition 20
on 3rd Oct 2024
Examiner's First Report
Submitted for opposition 223
on 3rd Oct 2024
Total Provisional Refusal
Submitted for opposition 22
on 27th Sept 2024
Search Recorded
Submitted for opposition 257
on 7th Dec 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 6th Dec 2023
Formalized
Submitted for opposition 1
on 6th Dec 2023
Created
Submitted for opposition 30
on 10th Nov 2023
Filed
Submitted for opposition 228
on 31st Jan 2018
International Registration